Chapter 2671 Progress in Biomedicine and Medical Devices
"In addition, our smart housekeeper series can also become excellent tutors for children. Through specialized parenting service robots, they can teach children some courses or skills, such as piano, violin, dance, and martial arts. Mr. Hu
It is to provide tutoring work for some cultural courses, etc.
It can even develop corresponding tutoring strategies and adjust methods according to the age of the child, thereby providing better educational tutoring for the child and allowing the child to feel the joy of learning.
As for smart office systems, they are mainly personal consumer products such as our smart tablets, transparent foldable tablets, smart computers, and smart host series equipped with our photonic chips.
For enterprise customers, we will also launch enterprise intelligent management systems and related hardware products. In addition, we will also launch enterprise-level small supercomputers and enterprise-level processors for enterprises.
Cluster series.
And this year we will also launch an intelligent workshop system for some small companies or studios.
This intelligent workshop system will integrate all turning, milling, planing, grinding, drilling, boring, punching, sawing, inserting, cutting, casting, forging, electro-corrosion, powder processing, electroplating, various heat treatments, etc.
The processing technology is centralized and all are automated. Designers or technicians only need to use special design software to design all relevant accessory models that need to be processed, and the rest is left to this intelligent workshop system to automatically process.
Compared with automatic machine tools on the market, this system is smarter and more automatic, and can produce many fine parts that meet the requirements. This can provide good practical experiments for these small studios and laboratory research institutes.
, it can also provide a comprehensive production workshop for small businesses to produce some fine parts.”
After introducing these in one breath, Yang Fan immediately took a breath and said: "Okay, these are the projects we are currently responsible for, and there are some other projects. For some reasons, I will not introduce them here."
What is the overall progress of these projects? Zhang Jun then asked Yang Fan.
Upon hearing Zhang Jun's inquiry, Yang Fan immediately replied: "All projects are progressing in an orderly manner. Some projects are progressing at a gratifying speed, but some projects still encounter some difficulties during the development process.
However, we can solve all these problems. It should not be a big problem and we can ensure that they are completed on time. But for some projects, the time may be a little tight, and it is definitely impossible to complete them on time, but we are also doing our best to push these
projects, so that they can speed up their progress and strive to complete them as soon as possible.”
Hearing Yang Fan's words, Wu Hao, who was sitting in the front seat, stopped writing and said: "There are some projects that do not need to be pushed forward forcefully, but should follow the trend. Don't rush to the schedule just to gain a little time, thereby creating a big project."
Piling up problems is not worth the gain.
After that, you can hold a meeting with the main responsible persons of the relevant project team, and then work out a reasonable work schedule, and then just push forward steadily according to this schedule. You can push it wherever you can. You must
The key is to play slowly and steadily.”
Hearing Wu Hao's words, Yang Fan nodded immediately, while Zhang Jun cast a doubtful look. However, at the meeting, he did not question Wu Hao's decision, especially in front of so many people.
"What about the biomedical field?" Zhang Jun then looked at Zhang Bin who was sitting in the distance.
Zhang Bin understood, then opened his folder and said to everyone: "Everyone knows that the progress in our biopharmaceutical field is very slow, mainly because biopharmaceuticals are related to the safety of human life, and orders cannot be careless.
Therefore, these pharmaceutical research and development projects we have are actually old projects that have been carried out for several years. The development work of these old projects is currently progressing smoothly. For example, our biological drugs for treating Helicobacter pylori have been approved for large-scale marketing and are currently on the market.
The response has been good, and it has been recognized and welcomed by both medical institutions and patients.
And currently this drug has been included in the list of therapeutic drugs to prevent and eliminate Helicobacter pylori infection. It is expected that this drug alone will earn us billions or even tens of billions of dollars in revenue every year in the future.
.
Next, our main work is to continue the Phase 4 and Phase 5 clinical trials of this drug, and to develop the patient use and treatment of this drug after it is launched on a large scale.
In addition, we will continue to promote the coverage and popularization of this drug in the global market and save more patients infected with Helicobacter pylori.
At present, we have reached relevant clinical trial access mechanisms with many countries and regions and are conducting small-batch clinical trials in these countries and regions. Once approved, large-scale marketing will begin in these countries and regions.
In addition to this drug, our other related drugs are also in the process of development, such as specific drugs for some diseases. The research and development work has also made great breakthroughs. It is expected that we will be able to enter clinical trials in the second half of the year.
In addition to these old projects, we have also started the research and development of some new drugs this year, especially the research and development of drugs for some common diseases. The research and development in this area is currently progressing smoothly, but if we want to get results, I am afraid it will take some time.
A very long time.”
Here are the smart medical devices. Zhang Jun nodded and then looked at Huang Zhixin, who was sitting next to Zhang Bin.
Hearing Zhang Jun's inquiry, Huang Zhixin also sat up, opened the document in front of him, and then said to Zhang Jun, Wu Hao, and everyone present: "Currently, our smart medical devices are mainly divided into two types. One is
Externally worn auxiliary devices, such as our intelligent bionic electronic prostheses, intelligent bionic electronic prosthetic eyes, intelligent medical mechanical exoskeleton products, etc.
There is another kind, which is for internal use, such as our intelligent bionic electronic organs. Currently, we are intensively developing this aspect, and many projects have made great progress. At present, our main direction is still in the overall
Appearance, weight and reliability.
We have already made the functions of these electronic organs very mature. Now one of the difficulties we are facing is how to reduce their size and weight so that they are the same size and weight as normal organs or even lighter and smaller. This is the only way
, we can implant these intelligent bionic electronic organs into the patient's body. If they are too big, they will definitely not be implanted.
On the other hand, in terms of reliability, we have to ensure that these smart bionic electronic organs are reliable enough. After all, this is related to the patient’s life safety and there is no room for error.”
